35 results on '"Brooks, B R"'
Search Results
2. Subcortical reorganization in amyotrophic lateral sclerosis
3. CD8 and CD4 T cell-mediated polymyositis complicating the HTLV-1 associated myelopathy. Quantitative evaluation of corticosteroid treatment
4. Normal modes for large molecules with arbitrary link constraints in the mobile block Hessian approach.
5. Theoretical study of the ground-state vibrations of the linear polyenes.
6. Transition from B to Z DNA: Contribution of Internal Fluctuations to the Configurational Entropy Difference
7. PATHOGENESIS OF MURINE RETROVIRUS INDUCED SPONGIOFORM ENCEPHALOMYELOPATHY
8. MURINE NEUROTROPIC RETROVIRUS: INFECTION OF DISSOCIATED MOUSE EMBRYONIC CENTRAL NERVOUS SYSTEM CULTURES IN VITRO
9. CHARMM: The biomolecular simulation program.
10. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial.
11. Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method.
12. Dissociation between mechanical and myoelectrical manifestation of muscle fatigue in amyotrophic lateral sclerosis.
13. Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: Beta-2 adrenergic agonists.
14. The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group.
15. Relationships between speech intelligibility and the slope of second-formant transitions in dysarthric subjects.
16. Home ventilation for amyotrophic lateral sclerosis patients.
17. Linkage analysis in familial amyotrophic lateral sclerosis.
18. Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis.
19. Norepinephrine and gamma-aminobutyric acid in amyotrophic lateral sclerosis.
20. SPONGIFORM POLIOENCEPHALOMYELOPATHY CAUSED BY A MURINE RETROVIRUS. II. ULTRASTRUCTURAL LOCALIZATION OF VIRUS REPLICATION AND SPONGIFORM CHANGES IN THE CENTRAL NERVOUS SYSTEM.
21. Slow Viral Infections.
22. Models of δ-hemolysin membrane channels and crystal structures.
23. Interaction of DNA with Bifunctional Aldehydes.
24. Hypoglossal, trigeminal, and facial motoneuron involvement in amyotrophic lateral sclerosis.
25. Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood cerebrospinal fluid barrier for norepinephrine.
26. Changes in Substance P (Sub P), 5-hydroxytryptamine (5-HT), and Thyrotropin-releasing Hormone (TRH)-like Immunoreactivity (LI) in Spinal Cord During Murine Neurotropic Retrovirus-induced Motor Neuron Degeneration.
27. Quantitative and Qualitative Differences in TRH Metabolism in NIH:N Mouse Brain and Spinal Cord.
28. Cerebrospinal Fluid Thyrotropin-releasing Hormone (TRH) Concentration Kinetics After Intravenous Thyrotropin-releasing Hormone Administration.
29. Spinal seizures following intravenous contrast in a patients with a cord AVM.
30. Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. 1998 [classical article].
31. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. 1995.
32. MURINE NEUROTROPIC RETROVIRUS.
33. Nonequilibrium Uptake Kinetics of 125I Thyrotropin-releasing Hormone (TRH) into Spinal Cord and Brain Following Intravenous, Intraperitoneal, or Subcutaneous Administration in NIH:N Mice.
34. 'Mineral transporter' therapy for multiple sclerosis complicated by bacterial endocarditis.
35. Erratum.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.